browse Browse

pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
010170f6-3c66-4ee0-81c3-eaab7d26236e
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-20 17:19:11
Income (reported)
$80,000
Expenses (reported)
Filing document
Open on lda.senate.gov

Registrant (lobbying firm)

WILLIAMS AND JENSEN, PLLC

Lobbying Law Firm

Contact
ISABELLA QUINN
Phone
+1 202-659-8201
Address
zip:20004, city:Washington, state:DC, street:1201 Pennsylvania Avenue, NW Suite 800

Client

BEONE MEDICINES ( FORMERLY KNOWN AS BEIGENE USA, INC.)

Healthcare/Pharmaceuticals

State
MA
Country
US
Effective date
2022-06-10

Issues lobbied + lobbyists

HCR — Health Issues

Monitor progress of next Prescription Drug User Fee Reauthorization, issues relating to US and international manufacturing, oncology issues, FDA reorganization and programs, 340B, monitoring efforts around direct-to-consumer policies.

Lobbyists:
  • SUSAN HIRSCHMANN
  • mr MATTHEW B HOEKSTRA
  • JEANNE HAGGERTY — covered position: Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

TRD — Trade (domestic/foreign)

Monitoring 232 investigations, monitoring tariffs, most favored nation drug pricing policies, pharmaceutical IP issues.

Lobbyists:
  • SUSAN HIRSCHMANN
  • mr MATTHEW B HOEKSTRA
  • JEANNE HAGGERTY — covered position: Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member
  • mr CHRISTOPHER W HATCHER

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

MMM — Medicare/Medicaid

Issues related to drug pricing and reimbursement for prescription drugs related to Inflation Reduction Act of 2022 (PL 117-169), Subtitle B (Part B and D drug pricing), access and coverage, most-favored nation drug pricing policies, ORPHAN Cures Act implementation.

Lobbyists:
  • SUSAN HIRSCHMANN
  • mr MATTHEW B HOEKSTRA
  • JEANNE HAGGERTY — covered position: Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member

Government entities lobbied: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

MAN — Manufacturing

Monitoring efforts to onshore and build US pharmaceutical manufacturing capacity.

Lobbyists:
  • SUSAN HIRSCHMANN
  • mr MATTHEW B HOEKSTRA
  • JEANNE HAGGERTY — covered position: Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

PHA — Pharmacy

H.R.830/S. 864, HELP Copays Act of 2023; Pharmacy Benefit Manager transparency, including Lower Costs, More Transparency Act.

Lobbyists:
  • SUSAN HIRSCHMANN
  • mr MATTHEW B HOEKSTRA
  • JEANNE HAGGERTY — covered position: Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.